Touchlight announces first FDA clearance of an IND utilising doggybone DNA Published: 28 February 2023 Enzymatic doggybone DNA material used in GMP production of a cell therapy by a US-based…
Read More
Category
Press Releases
Do you need support or have questions?
Find out how our cell-free DNA technology could accelerate your genetic medicine projects.
- Industry-leading expertise in enzymatic DNA production.
- Custom solutions tailored to your specific research needs.
- Scalable, high-purity DNA to support innovative therapies.
- Let’s drive innovation in genetic medicine with enzymatic DNA technology together.
Get the latest Touchlight news, trends and innovative solutions in genetic medicine.
Sign up for our newsletter, Cell-Free Insights
Touchlight pioneers scalable, cell-free DNA technology, transforming gene therapy and genetic medicine. With a commitment to innovation, excellence, and a diverse team, we push boundaries to deliver safer, more efficient solutions for the future.
© 2026 Touchlight Privacy Policy / Cookie Policy / Policies & Statements / Terms of Use / Suppliers / Biosecurity Commitment